Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W B Isaacs

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Cancer Research|October 1, 1996
Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic lossJ T Dong, H Suzuki, S S Pin, et al.
Cancer Research|June 15, 1992
Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11T Ichikawa, Y Ichikawa, J Dong, et al.
Cancer Research|November 26, 1997
Frequent inactivation of PTEN/MMAC1 in primary prostate cancerP Cairns, K Okami, S Halachmi, et al.
Cancer Research|July 15, 1994
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancerR Umbas, W B Isaacs, P P Bringuier, et al.
Cancer Research|September 15, 1992
Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancerR Umbas, J A Schalken, T W Aalders, et al.
Cancer Research|August 15, 1996
An uncertain role for p53 gene alterations in human prostate cancersJ D Brooks, G S Bova, C M Ewing, et al.
Cancer Research|December 16, 1998
Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cellsD F Jarrard, H Kinoshita, Y Shi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Allelic loss of chromosomes 16q and 10q in human prostate cancerB S Carter, C M Ewing, W S Ward, et al.
Prostate Cancer and Prostatic Diseases|September 17, 2014
Association of variants in genes related to the immune response and obesity with BPH in CLUE IID S Lopez, S B Peskoe, K K Tsilidis, et al.
Cancer Research|February 24, 2001
Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1C P Nelson, L C Kidd, J Sauvageot, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Cancer Research|October 1, 1996
Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic lossJ T Dong, H Suzuki, S S Pin, et al.
Cancer Research|June 15, 1992
Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11T Ichikawa, Y Ichikawa, J Dong, et al.
Cancer Research|November 26, 1997
Frequent inactivation of PTEN/MMAC1 in primary prostate cancerP Cairns, K Okami, S Halachmi, et al.
Cancer Research|July 15, 1994
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancerR Umbas, W B Isaacs, P P Bringuier, et al.
Cancer Research|September 15, 1992
Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancerR Umbas, J A Schalken, T W Aalders, et al.
Cancer Research|August 15, 1996
An uncertain role for p53 gene alterations in human prostate cancersJ D Brooks, G S Bova, C M Ewing, et al.
Cancer Research|December 16, 1998
Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cellsD F Jarrard, H Kinoshita, Y Shi, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Allelic loss of chromosomes 16q and 10q in human prostate cancerB S Carter, C M Ewing, W S Ward, et al.
Prostate Cancer and Prostatic Diseases|September 17, 2014
Association of variants in genes related to the immune response and obesity with BPH in CLUE IID S Lopez, S B Peskoe, K K Tsilidis, et al.
Cancer Research|February 24, 2001
Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1C P Nelson, L C Kidd, J Sauvageot, et al.
Pageof 12